FDA Approves Moderna's mRNA-Based Flu Vaccine

The U.S. Food and Drug Administration (FDA) has approved Moderna's mRNA-based flu vaccine, signaling a new type of flu shot becoming available. This development represents a significant advancement in public health and vaccine technology.